Intégration de la radiomique et des données génomiques pour prédire les résultats des traitements La radiomique analyse les images médicales. Elle extrait de nombreuses caractéristiques quantitatives. Parallèlement, la génomique étudie les altérations moléculaires des tumeurs. Aujourd’hui, les chercheurs combinent ces deux approches. Cette intégration améliore la prédiction des résultats thérapeutiques. Elle concerne surtout les tumeurs […]
Author: priyeshbanerjeept
Physiotherapist, Certified MFR therapist on a mission to provide one stop search destination for various diseases its symptoms,causes,diagnosis,treatment, physiotherapy management,rehabilitation with practical examples for aspiring physiotherapists,medical professionals and general public.
Biomarqueurs prédictifs de réponse et de résistance à la chimiothérapie à base de pémétrexed dans le mésothéliome pleural Le mésothéliome pleural malin reste un cancer agressif. Le pémétrexed associé à un sel de platine constitue depuis longtemps un traitement standard. Cependant, la réponse à cette chimiothérapie varie fortement selon les patients. Identifier des biomarqueurs prédictifs […]
Molecular Glues as a New Modality: Case Studies in Cereblon-Based Degraders for Hematologic Cancers Molecular glues represent an emerging class of therapeutic agents. These small molecules stabilize interactions between proteins. In doing so, they often trigger the degradation of disease-relevant targets. Unlike traditional inhibitors, molecular glues do not simply block protein function. Instead, they promote […]
Retifanlimab: A PD-1 Inhibitor for Rare and Difficult Cancers Retifanlimab is a modern immunotherapy drug. Doctors know it better by its brand name, Zynyz. Incyte Corporation developed this medication. It belongs to the class of PD-1 inhibitors. These drugs help the immune system fight cancer more effectively. How Retifanlimab Works Cancer cells often hide from […]
Predictive Biomarkers for CAR-T Cell Therapy Response: Integrating Cytokine Profiles, Tumor Antigen Density, and Patient Immune Signatures CAR-T cell therapy has transformed treatment for certain blood cancers. Many patients achieve deep and lasting remissions. However, responses remain highly variable. Some individuals experience rapid complete responses. Others show limited benefit or develop severe toxicities. Clinicians therefore […]
Neurocognitive Outcomes and School Performance in Children with Systemic Lupus Erythematosus and Neuropsychiatric Involvement Children with systemic lupus erythematosus often face neuropsychiatric complications. These complications can affect thinking, memory, and school performance. This research examines those effects through standardized testing and academic analysis. Researchers administer validated neuropsychological batteries. These tests measure attention, processing speed, memory, […]